WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Michael Nordtvedt
Partner
Corporate
Seattle
Palo Alto
mnordtvedt@wsgr.com

D206-883-2524

Download vCard
LinkedIn
Open PDF
  • Extensive Corporate and Securities Experience

    Michael specializes in corporate and securities law, including general corporate representation, public offerings, private placements, and mergers and acquisitions.

  • Wide Range of Clients

    He represents public and private technology, medical device, and life sciences companies at all stages of growth, in addition to investment banks and VC and private equity firms.

  • A Leader in His Field

    Michael is consistently recognized among the top practitioners in his field by Chambers USA: America's Leading Lawyers for Business.

Michael Nordtvedt currently leads the capital markets practice at Wilson Sonsini Goodrich & Rosati and is a partner at the firm’s Seattle and Palo Alto offices, where he focuses on the representation of public and private technology, medical device, and life sciences companies through all stages of their growth, as well as investment banks and venture capital and private equity firms.

Michael specializes in corporate and securities law, including general corporate representation, public offerings, private placements, and mergers and acquisitions. He also has considerable experience in counseling companies on complex governance, securities laws and disclosure issues. Michael frequently represents investment banks in their underwriting transactions and he also has broad transactional experience representing venture capital and private equity firms. Throughout the course of his career he has had responsibility for structuring and negotiating in excess of $40 billion in public and private financing transactions, for both companies and investment banks.

Prior to joining the firm in 2007, Michael practiced in the corporate group at Davis Polk & Wardwell in New York and Menlo Park, California. Michael also served in the United States Navy as an engineering officer aboard USS Lake Champlain (CG57), as executive and weapons officer aboard USS Monsoon (PC4), and at the Pentagon as an action officer responsible for international technology transfer issues.

Experience

Michael Nordtvedt currently leads the capital markets practice at Wilson Sonsini Goodrich & Rosati and is a partner at the firm’s Seattle and Palo Alto offices, where he focuses on the representation of public and private technology, medical device, and life sciences companies through all stages of their growth, as well as investment banks and venture capital and private equity firms.

Michael specializes in corporate and securities law, including general corporate representation, public offerings, private placements, and mergers and acquisitions. He also has considerable experience in counseling companies on complex governance, securities laws and disclosure issues. Michael frequently represents investment banks in their underwriting transactions and he also has broad transactional experience representing venture capital and private equity firms. Throughout the course of his career he has had responsibility for structuring and negotiating in excess of $40 billion in public and private financing transactions, for both companies and investment banks.

Prior to joining the firm in 2007, Michael practiced in the corporate group at Davis Polk & Wardwell in New York and Menlo Park, California. Michael also served in the United States Navy as an engineering officer aboard USS Lake Champlain (CG57), as executive and weapons officer aboard USS Monsoon (PC4), and at the Pentagon as an action officer responsible for international technology transfer issues.

Education
  • J.D., Georgetown University Law Center, 2001Magna Cum Laude; Order of the Coif; Editor, The Georgetown Law Journal
  • B.S.F.S., Georgetown University, 1994Magna Cum Laude, Phi Beta Kappa
Honors
  • Recognized in the 2014-2026 editions of Chambers USA: America's Leading Lawyers for Business
  • Named as an "Up-and-Coming" attorney in the 2014 edition of Chambers USA
  • Listed in the 2010-2012 editions of Washington Super Lawyers
Admissions
  • State Bar of California
  • State Bar of New York
  • State Bar of Washington
  • U.S. District Court for the Eastern District of New York
  • U.S. District Court for the Southern District of New York
Credentials
Education
  • J.D., Georgetown University Law Center, 2001Magna Cum Laude; Order of the Coif; Editor, The Georgetown Law Journal
  • B.S.F.S., Georgetown University, 1994Magna Cum Laude, Phi Beta Kappa
Honors
  • Recognized in the 2014-2026 editions of Chambers USA: America's Leading Lawyers for Business
  • Named as an "Up-and-Coming" attorney in the 2014 edition of Chambers USA
  • Listed in the 2010-2012 editions of Washington Super Lawyers
Admissions
  • State Bar of California
  • State Bar of New York
  • State Bar of Washington
  • U.S. District Court for the Eastern District of New York
  • U.S. District Court for the Southern District of New York

Select Clients

Companies represented in public offerings, private placements, mergers and acquisitions, and corporate law and governance include:

  • Agora
  • Alpine Immune Sciences
  • Apptio
  • Athira Pharma
  • Bardy Diagnostics
  • CorneaGen
  • CTI BioPharma
  • DigiCert
  • Domo
  • iHerb
  • Impinj
  • Juno Therapeutics
  • Kodiak Sciences
  • NanoString Technologies
  • Nohla Therapeutics
  • Onestream
  • POET
  • Rightside
  • Rover
  • Valent BioSciences
  • Vivint Solar

Investment banks represented in public offerings and private placements include:

  • Barclays
  • BofA Merrill Lynch
  • Citigroup
  • Credit Suisse
  • Deutsche Bank Securities
  • Goldman Sachs
  • Jefferies
  • J.P. Morgan
  • Leerink Partners
  • Morgan Stanley
  • RBC Capital Markets
Clients

Select Clients

Companies represented in public offerings, private placements, mergers and acquisitions, and corporate law and governance include:

  • Agora
  • Alpine Immune Sciences
  • Apptio
  • Athira Pharma
  • Bardy Diagnostics
  • CorneaGen
  • CTI BioPharma
  • DigiCert
  • Domo
  • iHerb
  • Impinj
  • Juno Therapeutics
  • Kodiak Sciences
  • NanoString Technologies
  • Nohla Therapeutics
  • Onestream
  • POET
  • Rightside
  • Rover
  • Valent BioSciences
  • Vivint Solar

Investment banks represented in public offerings and private placements include:

  • Barclays
  • BofA Merrill Lynch
  • Citigroup
  • Credit Suisse
  • Deutsche Bank Securities
  • Goldman Sachs
  • Jefferies
  • J.P. Morgan
  • Leerink Partners
  • Morgan Stanley
  • RBC Capital Markets

Select Publications

  • Co-author, "Guidance on Emerging Growth Companies," The Lexis Practice Advisor Journal, Spring 2017


Select Speaking Engagements

  • "SPACs: A Primer," NASPP New York/New Jersey Chapter webinar, June 16, 2021
  • "Summer 2021 IPO Bootcamp," Nasdaq Entrepreneurial Center webinar, June 9, 2021
  • "SPACs in 2021," Nasdaq Entrepreneurial Center webinar, March 17, 2021
  • "IPO and Liquidity Conference: Preparing for the Capital Markets," PricewaterhouseCoopers, RR Donnelley, Nasdaq, and Goldman Sachs, Seattle, Washington, June 2017
  • "2016 IPO and Liquidity Conference: Preparing for the Capital Markets," PricewaterhouseCoopers, Portland, Oregon, November 2016
  • "2016 IPO and Liquidity Conference: Preparing for the Capital Markets," PricewaterhouseCoopers, RR Donnelley, and Nasdaq, Seattle, Washington, and Vancouver, British Columbia, June 2016
  • "IPO Seminar," NASDAQ OMX, Seattle, Washington, September 2014
  • "Securities Filings 2013: Practical Guidance in a Changing Environment," Practicing Law Institute, New York, New York, September 2013
  • "IPO Seminar," NASDAQ OMX, Seattle, Washington, April 2013
  • "Taking Advantage of the JOBS Act," Law Seminars International, Seattle, Washington, May 2012
  • "Managing the IPO Process in Times of Market Volatility: Legal and Practical Cons," Thomson Reuters webcast (West LegalEdcenter), October 2011
Insights

Select Publications

  • Co-author, "Guidance on Emerging Growth Companies," The Lexis Practice Advisor Journal, Spring 2017


Select Speaking Engagements

  • "SPACs: A Primer," NASPP New York/New Jersey Chapter webinar, June 16, 2021
  • "Summer 2021 IPO Bootcamp," Nasdaq Entrepreneurial Center webinar, June 9, 2021
  • "SPACs in 2021," Nasdaq Entrepreneurial Center webinar, March 17, 2021
  • "IPO and Liquidity Conference: Preparing for the Capital Markets," PricewaterhouseCoopers, RR Donnelley, Nasdaq, and Goldman Sachs, Seattle, Washington, June 2017
  • "2016 IPO and Liquidity Conference: Preparing for the Capital Markets," PricewaterhouseCoopers, Portland, Oregon, November 2016
  • "2016 IPO and Liquidity Conference: Preparing for the Capital Markets," PricewaterhouseCoopers, RR Donnelley, and Nasdaq, Seattle, Washington, and Vancouver, British Columbia, June 2016
  • "IPO Seminar," NASDAQ OMX, Seattle, Washington, September 2014
  • "Securities Filings 2013: Practical Guidance in a Changing Environment," Practicing Law Institute, New York, New York, September 2013
  • "IPO Seminar," NASDAQ OMX, Seattle, Washington, April 2013
  • "Taking Advantage of the JOBS Act," Law Seminars International, Seattle, Washington, May 2012
  • "Managing the IPO Process in Times of Market Volatility: Legal and Practical Cons," Thomson Reuters webcast (West LegalEdcenter), October 2011
Focus Areas
  • Biotech
  • Capital Markets
  • Clean Energy
  • Communications and Networking
  • Consumer Products and Services
  • Corporate
  • Corporate Governance
  • Corporate Life Sciences
  • Emerging Companies and Venture Capital
  • Environmental, Social, and Governance
  • Internet
  • Life Sciences
  • Mergers & Acquisitions
  • Special Purpose Acquisition Companies (SPACs)
Recent Insights
Alerts
SEC Proposes Significant Registered Offering Reforms to Increase Public Market Access
On May 19, 2026, the U.S. Securities and Exchange Commission (the SEC or Commission) announced proposed rule and form amendments that would substantially revise the framework for registered securities offerings by U.S. public companies. The proposal is intended to facilitate capital formation by broadening access to short-form registration, expanding offering communications flexibility, and reducing certain procedural burdens associated with registered offerings, while maintaining robust investor protections.
Learn More
Alerts
SEC Proposes Streamlining Filer Status Framework and Broadening Availability of Scaled Disclosures
On May 19, 2026, the U.S. Securities and Exchange Commission (the SEC or Commission) announced proposed rule and form amendments that would streamline the existing filer status framework and extend many of today’s scaled disclosure requirements and accommodations to a significantly larger portion of reporting companies. The proposal is intended to better align disclosure and compliance obligations with issuer size and maturity while preserving core investor protections. The Commission estimates that approximately 81 percent of reporting companies would qualify for scaled disclosure under the proposal, although large accelerated filers would continue to represent the majority of the U.S. equity market capitalization.
Learn More
View All
Recent Events
Speaking Engagements
IPO Readiness 2026 Webinar with Deloitte and J.P. Morgan
Join Wilson Sonsini, Deloitte, and J.P. Morgan for an exclusive webinar, “IPO Readiness 2026: The New Bar for Life Sciences & Health Care,” designed for C-suite and decision makers from life sciences and health care companies, investors, and entrepreneurs.
Learn More
Affiliated Programs
Circle|Summit 2026
Wilson Sonsini is proud to sponsor The Circle and MUFG’s exclusive leadership retreat, a two-and-a-half day program designed for influential CFOs from growth-stage and newly public companies. 
Learn More
View All
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.